A comparison of apremilast monotherapy and combination therapy for psoriatic arthritis in a real-life setting: Data from the Leeds Combined Psoriatic Service

Abignano, G, Fadl, N, Merashli, M et al. (4 more authors) (2019) A comparison of apremilast monotherapy and combination therapy for psoriatic arthritis in a real-life setting: Data from the Leeds Combined Psoriatic Service. Journal of the American Academy of Dermatology, 80 (6). pp. 1796-1798. ISSN 0190-9622

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 by the American Academy of Dermatology, Inc. This is an author produced version of a paper published in Journal of The American Academy of Dermatology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Psoriasis; psoriatic arthritis; spondiloarthropathy; apremilast; PDE4 inhibitor; phosphodiesterase-4 inhibitor; PDE4 inhibition; phosphodiesterase-4 inhibition; otezla
Dates:
  • Accepted: 6 February 2019
  • Published (online): 13 February 2019
  • Published: June 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Mar 2019 11:31
Last Modified: 13 Feb 2020 01:38
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jaad.2019.02.014
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)